no mention of BpEye, xoma even has the chance of being the only drug (unless one believe that Mexico study)that works via a systemic delivery, as tough as it is to get injected in veins or IM or SC, it is tougher to get the stuff directly into your eye.
Why acne, why the mlnm dust (ooops, drugs)why arthritis, why Ing1, why transplant, and now to look for "another molecule" with a small partner, ACQUIRING MOOD, ceoperson was really happy with the Fda panel, keep singing that Rap, rap, rap!
Shooting all over the place!
Forget a new molecule from a "small partner", xoma needs many big partners, got the Pdli way taking 3% to 5% with many BIG partners.
Then put the sure money in BpEye
Hey, maybe the guy
does not believe
in bpi
burn once in trauma,
in meningo burn twice,
shoot all over the place
but bpi |
